122 related articles for article (PubMed ID: 15927706)
21. A hypoxia-driven vascular endothelial growth factor/Flt1 autocrine loop interacts with hypoxia-inducible factor-1alpha through mitogen-activated protein kinase/extracellular signal-regulated kinase 1/2 pathway in neuroblastoma.
Das B; Yeger H; Tsuchida R; Torkin R; Gee MF; Thorner PS; Shibuya M; Malkin D; Baruchel S
Cancer Res; 2005 Aug; 65(16):7267-75. PubMed ID: 16103078
[TBL] [Abstract][Full Text] [Related]
22. Neuropeptide Y and its Y2 receptor: potential targets in neuroblastoma therapy.
Lu C; Everhart L; Tilan J; Kuo L; Sun CC; Munivenkatappa RB; Jönsson-Rylander AC; Sun J; Kuan-Celarier A; Li L; Abe K; Zukowska Z; Toretsky JA; Kitlinska J
Oncogene; 2010 Oct; 29(41):5630-42. PubMed ID: 20676138
[TBL] [Abstract][Full Text] [Related]
23. Introduction to the reviews on neuropeptide Y.
Gehlert DR
Neuropeptides; 2004 Aug; 38(4):135-40. PubMed ID: 15337366
[TBL] [Abstract][Full Text] [Related]
24. High expression of neuropeptide y receptors in tumors of the human adrenal gland and extra-adrenal paraganglia.
Körner M; Waser B; Reubi JC
Clin Cancer Res; 2004 Dec; 10(24):8426-33. PubMed ID: 15623622
[TBL] [Abstract][Full Text] [Related]
25. Mitochondrial targeting signal in human neuropeptide Y gene.
Kaipio K; Kallio J; Pesonen U
Biochem Biophys Res Commun; 2005 Nov; 337(2):633-40. PubMed ID: 16199004
[TBL] [Abstract][Full Text] [Related]
26. Presence of neuropeptide Y in somatotrophs of cattle.
Ogasawara H; Aso H; Nagai Y; Matsumoto K; Okamura H; Tanaka S; Watanabe K; Ohwada S; Yamaguchi T
Domest Anim Endocrinol; 2008 Oct; 35(3):274-80. PubMed ID: 18678462
[TBL] [Abstract][Full Text] [Related]
27. Regulation of endogenous human NPFF2 receptor by neuropeptide FF in SK-N-MC neuroblastoma cell line.
Ankö ML; Panula P
J Neurochem; 2006 Jan; 96(2):573-84. PubMed ID: 16336216
[TBL] [Abstract][Full Text] [Related]
28. Neuropeptide Y receptors; antisecretory control of intestinal epithelial function.
Cox HM
Auton Neurosci; 2007 Apr; 133(1):76-85. PubMed ID: 17140858
[TBL] [Abstract][Full Text] [Related]
29. Regulation of vitamin D receptor expression via estrogen-induced activation of the ERK 1/2 signaling pathway in colon and breast cancer cells.
Gilad LA; Bresler T; Gnainsky J; Smirnoff P; Schwartz B
J Endocrinol; 2005 Jun; 185(3):577-92. PubMed ID: 15930183
[TBL] [Abstract][Full Text] [Related]
30. Properties of the N-terminal domains from Y receptors probed by NMR spectroscopy.
Zou C; Kumaran S; Walser R; Zerbe O
J Pept Sci; 2009 Mar; 15(3):184-91. PubMed ID: 19125388
[TBL] [Abstract][Full Text] [Related]
31. Neuropeptide Y as a partial agonist of the Y1 receptor.
Sah R; Balasubramaniam A; Parker MS; Sallee F; Parker SL
Eur J Pharmacol; 2005 Nov; 525(1-3):60-8. PubMed ID: 16293244
[TBL] [Abstract][Full Text] [Related]
32. Inhibition of MAPK-signaling pathway promotes the interaction of the corepressor SMRT with the human androgen receptor and mediates repression of prostate cancer cell growth in the presence of antiandrogens.
Eisold M; Asim M; Eskelinen H; Linke T; Baniahmad A
J Mol Endocrinol; 2009 May; 42(5):429-35. PubMed ID: 19223455
[TBL] [Abstract][Full Text] [Related]
33. Protein kinase C zeta mediates epidermal growth factor-induced growth of head and neck tumor cells by regulating mitogen-activated protein kinase.
Cohen EE; Lingen MW; Zhu B; Zhu H; Straza MW; Pierce C; Martin LE; Rosner MR
Cancer Res; 2006 Jun; 66(12):6296-303. PubMed ID: 16778206
[TBL] [Abstract][Full Text] [Related]
34. Y(1)-mediated effect of neuropeptide Y in cancer: breast carcinomas as targets.
Reubi JC; Gugger M; Waser B; Schaer JC
Cancer Res; 2001 Jun; 61(11):4636-41. PubMed ID: 11389101
[TBL] [Abstract][Full Text] [Related]
35. Changes of brain neuropeptide Y and its receptors in rats with flurazepam tolerance and dependence.
Zhang LP; Wang L
Acta Pharmacol Sin; 2005 Nov; 26(11):1290-6. PubMed ID: 16225749
[TBL] [Abstract][Full Text] [Related]
36. Activation of neuropeptide Y Y1 receptors inhibits glutamate release through reduction of voltage-dependent Ca2+ entry in the rat cerebral cortex nerve terminals: suppression of this inhibitory effect by the protein kinase C-dependent facilitatory pathway.
Wang SJ
Neuroscience; 2005; 134(3):987-1000. PubMed ID: 16026936
[TBL] [Abstract][Full Text] [Related]
37. Regulation and expression of D-1, but not D-5, dopamine receptors in human SK-N-MC neuroblastoma cells.
Sidhu A
J Recept Signal Transduct Res; 1997 Sep; 17(5):777-84. PubMed ID: 9292777
[TBL] [Abstract][Full Text] [Related]
38. Pancreatic polypeptide is secreted from and controls differentiation through its specific receptors in osteoblastic MC3T3-E1 cells.
Hosaka H; Nagata A; Yoshida T; Shibata T; Nagao T; Tanaka T; Saito Y; Tatsuno I
Peptides; 2008 Aug; 29(8):1390-5. PubMed ID: 18440094
[TBL] [Abstract][Full Text] [Related]
39. Mitogen-activated protein kinase (MAPK) blockade of bovine preimplantation embryogenesis requires inhibition of both p38 and extracellular signal-regulated kinase (ERK) pathways.
Madan P; Calder MD; Watson AJ
Reproduction; 2005 Jul; 130(1):41-51. PubMed ID: 15985630
[TBL] [Abstract][Full Text] [Related]
40. Y1 receptor of neuropeptide Y as a glial marker in proliferative vitreoretinopathy and diseased human retina.
Cantó Soler MV; Gallo JE; Dodds RA; Hökfelt T; Villar MJ; Suburo AM
Glia; 2002 Sep; 39(3):320-4. PubMed ID: 12203398
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
